Integrative biology identifies shared transcriptional networks in CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 11, 2014, Pages 2559-2572

  Martini, Sebastian ^a,b   Nair, Viji ^a,b   Keller, Benjamin J ^c   Eichinger, Felix ^a,b   Hawkins, Jennifer J ^a,b   Randolph, Ann ^a,b   Böger, Carsten A ^d   Gadegbeku, Crystal A ^e   Fox, Caroline S ^f,g   Cohen, Clemens D ^h   Kretzler, Matthias ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c EASTERN MICHIGAN UNIVERSITY   (United States)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR NRF2; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHRONIC KIDNEY FAILURE; DISEASE COURSE; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; NORTH AMERICA; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADULT; AGED; DATABASES, GENETIC; DISEASE PROGRESSION; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; POLYMORPHISM, SINGLE NUCLEOTIDE; RENAL INSUFFICIENCY, CHRONIC; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; YOUNG ADULT;

EID: 84924009565     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013080906     Document Type: Article

References (47)

1. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, US Renal Data System, 2010
2. Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D: Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24: 1506-1523, 2009
3. Sharma S, Sirin Y, Susztak K: The story of Notch and chronic kidney disease. Curr Opin Nephrol Hypertens 20: 56-61, 2011
4. Ly J, Alexander M, Quaggin SE: A podocentric view of nephrology. Curr Opin Nephrol Hypertens 13: 299-305, 2004
5. Zoja C, Abbate M, Remuzzi G: Progression of chronic kidney disease: Insights from animal models. Curr Opin Nephrol Hypertens 15: 250-257, 2006
6. Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE: Biomarkers in chronic kidney disease: A review. Kidney Int 80: 806-821, 2011
7. Köttgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, Yang Q, Gudnason V, Launer LJ, Harris TB, Smith AV, Arking DE, Astor BC, Boerwinkle E, Ehret GB, Ruczinski I, Scharpf RB, Chen YD, de Boer IH, Haritunians T, Lumley T, Sarnak M, Siscovick D, Benjamin EJ, Levy D, Upadhyay A, Aulchenko YS, Hofman A, Rivadeneira F, Uitterlinden AG, van Duijn CM, Chasman DI, Paré G, Ridker PM, Kao WH, Witteman JC, Coresh J, Shlipak MG, Fox CS: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712-717, 2009
8. Köttgen A, Pattaro C, Böger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Paré G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tönjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, Feitosa M, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N, Meisinger C, Wichmann HE, Koenig W, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstätter A, Kollerits B, Kedenko L, Mägi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Völzke H, Kroemer HK, Nauck M, Völker U, Polasek O, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Krämer BK, Rudan I, Gyllensten U, Wilson JF, Witteman JC, Pramstaller PP, Rettig R, Hastie N, Chasman DI, Kao WH, Heid IM, Fox CS: New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384, 2010
9. Rodríguez-Iturbe B, García García G: The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 116: c81-c88, 2010
10. Leblond FA, Giroux L, Villeneuve JP, Pichette V: Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab Dispos 28: 1317-1320, 2000
11. Naud J, Michaud J, Beauchemin S, Hébert MJ, Roger M, Lefrancois S, Leblond FA, Pichette V: Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos 39: 1363-1369, 2011
12. Vaziri ND: Dyslipidemia of chronic renal failure: The nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290: F262-F272, 2006
13. Song J, Singh M: How and when should interactome-derived clusters be used to predict functional modules and protein function? Bioinformatics 25: 3143-3150, 2009
14. Sauna ZE, Kimchi-Sarfaty C: Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12: 683-691, 2011
15. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP: Allelic variation in gene expression is common in the human genome. Genome Res 13: 1855-1862, 2003
16. Mohtat D, Susztak K: Fine tuning gene expression: The epigenome. Semin Nephrol 30: 468-476, 2010
17. Perco P, Oberbauer R: Integrative analysis of -omics data and histologic scoring in renal disease and transplantation: Renal histogenomics. Semin Nephrol 30: 520-530, 2010
18. Spasovski G, Ortiz A, Vanholder R, El Nahas M: Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for. Proteomics Clin Appl 5: 233-240, 2011
19. Keller BJ, Martini S, Sedor JR, Kretzler M: A systems view of genetics in chronic kidney disease. Kidney Int 81: 14-21, 2012
20. Wang K, Li M, Bucan M: Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 81: 1278-1283, 2007
21. Mak RH, Cheung W, Cone RD, Marks DL: Mechanisms of disease: Cytokine and adipokine signaling in uremic cachexia. Nat Clin Pract Nephrol 2: 527-534, 2006
22. Slee AD: Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab (Lond) 9: 36, 2012
23. Vondrácek J, Umannová L, Machala M: Interactions of the aryl hydrocarbon receptor with in flammatory mediators: Beyond CYP1A regulation. Curr Drug Metab 12: 89-103, 2011
24. Reiff C, Delday M, Rucklidge G, Reid M, Duncan G, Wohlgemuth S, Hörmannsperger G, Loh G, Blaut M, Collie-Duguid E, Haller D, Kelly D: Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 15: 1721-1736, 2009
25. Handschin C, Podvinec M, Stöckli J, Hoffmann K, Meyer UA: Conservation of signaling pathways of xenobiotic-sensing orphan nuclear receptors, chicken xenobiotic receptor, constitutive androstane receptor, and pregnane X receptor, from birds to humans. Mol Endocrinol 15: 1571-1585, 2001
26. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA: Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A 93: 6731-6736, 1996
27. Suzuki T, Toyohara T, Akiyama Y, Takeuchi Y, Mishima E, Suzuki C, Ito S, Soga T, Abe T: Transcriptional regulation of organic anion transporting polypeptide SLCO4C1 as a new therapeutic modality to prevent chronic kidney disease. J Pharm Sci 100: 3696-3707, 2011
28. Del Vecchio L, Locatelli F, Carini M: What we know about oxidative stress in patients with chronic kidney disease on dialysis - clinical effects, potential treatment, and prevention. Semin Dial 24: 56-64, 2011
29. Granata S, Zaza G, Simone S, Villani G, Latorre D, Pontrelli P, Carella M, Schena FP, Grandaliano G, Pertosa G: Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10: 388, 2009
30. Kuchta A, Pacanis A, Kortas-Stempak B, Cwiklińska A, Ziêtkiewicz M, Renke M, Rutkowski B: Estimation of oxidative stress markers in chronic kidney disease. Kidney Blood Press Res 34: 12-19, 2011
31. Khan HY, Zubair H, Ullah MF, Ahmad A, Hadi SM: A prooxidant mechanismfor the anticancer and chemopreventive properties of plant polyphenols. Curr Drug Targets 13: 1738-1749, 2012
32. Pergola PE, Raskin P, Toto RD, Meyer CJ, Huff JW, Grossman EB, Krauth M, Ruiz S, Audhya P, Christ-Schmidt H, Wittes J, Warnock DG; BEAM Study Investigators: Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365: 327-336, 2011
33. Zoja C, Benigni A, Remuzzi G: The Nrf2 pathway in the progression of renal disease. Nephrol Dial Transplant 29[Suppl 1]: S19-S24, 2014
34. Bohle A, Mackensen-Haen S, von Gise H, Grund KE, Wehrmann M, Batz C, Bogenschütz O, Schmitt H, Nagy J, Müller C: The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract 186: 135-144, 1990
35. Samarakoon R, Dobberfuhl AD, Cooley C, Overstreet JM, Patel S, Goldschmeding R, Meldrum KK, Higgins PJ: Induction of renal fibrotic genes by TGF-b1 requires EGFR activation, p53 and reactive oxygen species. Cell Signal 25: 2198-2209, 2013
36. Berthier CC, Bethunaickan R, Gonzalez-Rivera T, Nair V, Ramanujam M, Zhang W, Bottinger EP, Segerer S, Lindenmeyer M, Cohen CD, Davidson A, Kretzler M: Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J Immunol 189: 988-1001, 2012
37. Hodgin JB, Nair V, Zhang H, Randolph A, Harris RC, Nelson RG, Weil EJ, Cavalcoli JD, Patel JM, Brosius FC 3rd, Kretzler M: Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes 62: 299-308, 2013
38. Martini S, Nair V, Patel SR, Eichinger F, Nelson RG, Weil EJ, Pezzolesi MG, Krolewski AS, Randolph A, Keller BJ, Werner T, Kretzler M: From single nucleotide polymorphism to transcriptional mechanism: A model for FRMD3 in diabetic nephropathy. Diabetes 62: 2605-2612, 2013
39. Martini S, Eichinger F, Nair V, Kretzler M: Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord 9: 267-274, 2008
40. Cohen CD, Frach K, Schlöndorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: A novel protocol for a high-throughput multicenter application. Kidney Int 61: 133-140, 2002
41. Schmid H, Boucherot A, Yasuda Y, Henger A, Brunner B, Eichinger F, Nitsche A, Kiss E, Bleich M, Gröne HJ, Nelson PJ, Schlöndorff D, Cohen CD, Kretzler M; European Renal cDNA Bank (ERCB) Consortium: Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55: 2993-3003, 2006
42. Johnson WE, Li C, Rabinovic A: Adjusting batch effects in microarray expression data using empirical Bayesmethods. Biostatistics 8: 118-127, 2007
43. Thacker SG, Berthier CC, Mattinzoli D, Rastaldi MP, Kretzler M, Kaplan MJ: The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: Potential role in atherogenesis and renal vascular rarefaction. J Immunol 185: 4457-4469, 2010
44. Fessele S, Maier H, Zischek C, Nelson PJ, Werner T: Regulatory context is a crucial part of gene function. Trends Genet 18: 60-63, 2002
45. Huang W, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009
46. Tarcea VG, Weymouth T, Ade A, Bookvich A, Gao J, Mahavisno V, Wright Z, Chapman A, Jayapandian M, Ozgür A, Tian Y, Cavalcoli J, Mirel B, Patel J, Radev D, Athey B, States D, Jagadish HV: Michigan molecular interactions r2: From interacting proteins to pathways. Nucleic Acids Res 37: D642-D646, 2009
47. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, Workman C, Christmas R, Avila-Campilo I, Creech M, Gross B, Hanspers K, Isserlin R, Kelley R, Killcoyne S, Lotia S, Maere S, Morris J, Ono K, Pavlovic V, Pico AR, Vailaya A, Wang PL, Adler A, Conklin BR, Hood L, Kuiper M, Sander C, Schmulevich I, Schwikowski B, Warner GJ, Ideker T, Bader GD: Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2: 2366-2382, 2007